근시 및 노안 치료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Myopia and Presbyopia Treatment Market size is expected to reach USD 61.10 Billion in 2034 from USD 27.51 Billion (2025) growing at a CAGR of 9.27% during 2026-2034.

The Global Myopia and Presbyopia Treatment Market is growing steadily due to the rising number of people experiencing vision problems across all age groups. Increasing screen time, digital device usage, and changing lifestyles are contributing to a higher prevalence of myopia among children and young adults. At the same time, the aging population worldwide is driving demand for presbyopia treatments. This combination of demographic and lifestyle factors is supporting consistent market expansion globally.

Key growth drivers include technological advancements in corrective lenses, laser surgeries, and pharmaceutical eye drops. Innovations in minimally invasive procedures and customized vision correction solutions are attracting more patients. Growing awareness about early eye testing and preventive eye care is also increasing treatment adoption. In addition, better access to ophthalmology clinics and eye care services in emerging economies is supporting market growth.

In the future, the market is expected to benefit from ongoing research in advanced contact lenses, smart glasses, and novel drug therapies. Companies are investing in long-term solutions that slow myopia progression in children. The expansion of tele-optometry and digital eye screening tools will further enhance accessibility. As eye health becomes a priority, the market is projected to witness strong and sustainable growth in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Myopia Treatment Type

• Corrective
• Surgical
• Drugs

By Presbyopia Treatment Type

• Prescription Lenses
• Contact Lenses
• Intraocular Lenses
• Refractive Surgery

COMPANIES PROFILED

• Ziemer Ophthalmic Systems AG, Nidek Co Ltd, Johnson Johnson Vision, Essilor Ltd, Zeiss International, Alcon Vision LLC, Bausch Lomb Incorporated, HaagStreit UK, Topcon Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MYOPIA AND PRESBYOPIA TREATMENT MARKET: BY MYOPIA TREATMENT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Myopia Treatment Type
• 4.2. Corrective Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Surgical Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MYOPIA AND PRESBYOPIA TREATMENT MARKET: BY PRESBYOPIA TREATMENT TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Presbyopia Treatment Type
• 5.2. Prescription Lenses Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Contact Lenses Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Intraocular Lenses Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Refractive Surgery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MYOPIA AND PRESBYOPIA TREATMENT MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Myopia Treatment Type
  • 6.2.2 By Presbyopia Treatment Type
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Myopia Treatment Type
  • 6.3.2 By Presbyopia Treatment Type
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Myopia Treatment Type
  • 6.4.2 By Presbyopia Treatment Type
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Myopia Treatment Type
  • 6.5.2 By Presbyopia Treatment Type
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Myopia Treatment Type
  • 6.6.2 By Presbyopia Treatment Type
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL MYOPIA AND PRESBYOPIA TREATMENT INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Ziemer Ophthalmic Systems AG
  • 8.2.2 Nidek Co. Ltd
  • 8.2.3 Johnson & Johnson Vision
  • 8.2.4 Essilor Ltd
  • 8.2.5 Zeiss International
  • 8.2.6 Alcon Vision LLC
  • 8.2.7 Bausch & Lomb Incorporated
  • 8.2.8 Haag-Streit UK
  • 8.2.9 Topcon Corporation